X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (153) 153
index medicus (100) 100
male (80) 80
middle aged (73) 73
female (72) 72
gastroenterology & hepatology (71) 71
hepatocellular carcinoma (58) 58
aged (53) 53
liver cancer (53) 53
liver (49) 49
liver neoplasms - therapy (47) 47
cancer (46) 46
oncology (46) 46
microspheres (43) 43
radioembolization (39) 39
carcinoma, hepatocellular - therapy (34) 34
surgery (33) 33
survival (33) 33
adult (32) 32
liver neoplasms - radiotherapy (31) 31
transplantation (30) 30
treatment outcome (29) 29
liver neoplasms - pathology (27) 27
embolization, therapeutic - methods (26) 26
liver transplantation (26) 26
retrospective studies (26) 26
tumors (26) 26
animals (24) 24
carcinoma, hepatocellular - pathology (23) 23
hepatocellular-carcinoma (21) 21
hepatoma (21) 21
chemotherapy (20) 20
carcinoma, hepatocellular - radiotherapy (19) 19
gastroenterology and hepatology (19) 19
gene therapy (19) 19
yttrium radioisotopes - therapeutic use (19) 19
care and treatment (18) 18
liver neoplasms - mortality (18) 18
radiology, nuclear medicine & medical imaging (18) 18
risk factors (18) 18
y-90 microspheres (18) 18
analysis (17) 17
chemoembolization (17) 17
immunotherapy (17) 17
prognosis (17) 17
embolization, therapeutic - adverse effects (16) 16
patients (16) 16
selective internal radiation therapy (16) 16
sorafenib (16) 16
therapy (16) 16
liver cirrhosis (15) 15
carcinoma, hepatocellular - mortality (14) 14
cirrhosis (14) 14
clinical trials (14) 14
metastases (14) 14
radiotherapy (14) 14
transarterial chemoembolization (14) 14
yttrium-90 (14) 14
embolization, therapeutic (13) 13
follow-up studies (13) 13
hepatology (13) 13
safety (13) 13
yttrium radioisotopes - administration & dosage (13) 13
disease (12) 12
genetic therapy - methods (12) 12
liver - pathology (12) 12
liver neoplasms - surgery (12) 12
sirt (12) 12
survival rate (12) 12
yttrium radioisotopes - adverse effects (12) 12
genetic vectors (11) 11
liver neoplasms (11) 11
liver neoplasms - blood supply (11) 11
liver neoplasms - drug therapy (11) 11
liver neoplasms - secondary (11) 11
medicine & public health (11) 11
mice (11) 11
neoplasm staging (11) 11
survival analysis (11) 11
brachytherapy - methods (10) 10
dendritic cells (10) 10
health aspects (10) 10
hepatic artery (10) 10
in-vivo (10) 10
liver diseases (10) 10
management (10) 10
rare earth metals (10) 10
adenoviridae - genetics (9) 9
brachytherapy (9) 9
carcinoma, hepatocellular - drug therapy (9) 9
efficacy (9) 9
hemodynamics (9) 9
liver transplantation - adverse effects (9) 9
multivariate analysis (9) 9
prospective studies (9) 9
radiofrequency ablation (9) 9
recurrence (9) 9
yttrium (9) 9
carcinoma, hepatocellular - surgery (8) 8
clinical trials as topic (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 11/2017, Volume 77, Issue 22 Supplement, pp. IA25 - IA25
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2492 - 2502
Summary Background For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor. We aimed to... 
Internal Medicine | CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | IMMUNOTHERAPY | SORAFENIB | BLOCKADE | DOCETAXEL | PD-1 | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Slopes | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Medical services | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety engineering | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis
Journal Article
Nature Reviews Gastroenterology and Hepatology, ISSN 1759-5045, 12/2015, Volume 12, Issue 12, pp. 681 - 700
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2018, Volume 24, Issue 7, pp. 1518 - 1524
Journal Article
Hepatology, ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 981 - 982
Journal Article
Hepatology, ISSN 0270-9139, 03/2012, Volume 55, Issue 3, p. 981
Journal Article
Hepatology, ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 981 - 982
Journal Article
Hepatology, ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 981 - 982
Journal Article
Journal of Hepatology, ISSN 0168-8278, 01/2018, Volume 68, Issue 1, p. 157
Drug development in hepatocellular carcinoma (HCC) has been characterised by many failures in the past. Despite good rationales and promising phase II data,... 
Liver cancer | Immune checkpoint | Immunotherapy | Clinical trials | Hepatocellular carcinoma | Drug development
Journal Article
Gastroenterologia y Hepatologia, ISSN 0210-5705, 2014, Volume 37, Issue 2, pp. 95 - 101
The two intraarterial techniques used in the treatment of hepatocellular carcinoma (HCC) are the transarterial chemoembolization (TACE) and radioembolization... 
Microspheres | Sorafenib | Eluting beads | Radioembolization | Chemoembolization
Journal Article
Gastroenterología y Hepatología, ISSN 0210-5705, 2014, Volume 37, pp. 95 - 101
Resumen Las dos técnicas intraarteriales utilizadas en el tratamiento del carcinoma hepatocelular (CHC) son la quimioembolización transarterial (TACE) y la... 
Gastroenterology and Hepatology | Microspheres | Sorafenib | Radioembolización | Partículas eluyentes | Eluting beads | Quimioembolización | Radioembolization | Microesferas | Chemoembolization
Journal Article
Gastroenterologia y hepatologia, ISSN 0210-5705, 07/2014, Volume 37 Suppl 2, p. 95
The two intraarterial techniques used in the treatment of hepatocellular carcinoma (HCC) are the transarterial chemoembolization (TACE) and radioembolization... 
Chemoembolization, Therapeutic - methods | Carcinoma, Hepatocellular - mortality | Humans | Brachytherapy - methods | Survival Rate | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Injections, Intra-Arterial
Journal Article
Journal of Hepatology, ISSN 0168-8278, 01/2018, Volume 68, Issue 1, pp. 157 - 166
Drug development in hepatocellular carcinoma (HCC) has been characterised by many failures in the past. Despite good rationales and promising phase II data,... 
HCC | Immunotherapy | Cancer | ADVANCED HEPATOCELLULAR-CARCINOMA | DENDRITIC CELLS | CLINICAL-TRIAL | PD-1 BLOCKADE | ACQUIRED-RESISTANCE | UNTREATED MELANOMA | T-CELL-ACTIVATION | POSTOPERATIVE RECURRENCE | PHASE-3 TRIAL | DOUBLE-BLIND | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Journal of Hepatology, ISSN 0168-8278, 06/2017, Volume 66, Issue 6, p. 1114
Bruix et al present an assessment of treatment efficacy in hepatocellular carcinoma, with focus on response rate, delay in progression, or none of them. The... 
Liver cancer | Medical treatment | Hepatocellular carcinoma | Survival | Clinical outcomes | Tumors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.